Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Medtronic reveals cardiac mapping and ablation software clearances

1 October 2026 · By · Wire by Fusion42

Published

1 October 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at medtechdive.com →

◆ Verified

Fusion42 · 1 October 2026 · Fusion42 review

Medtronic has received regulatory authorizations for cardiac mapping and ablation software as it aims to set itself apart in the growing pulsed field ablation market alongside rivals Abbott, Boston Scientific, and Johnson & Johnson.

This Wire brief sits within Fusion42's coverage of Medtech, and 2 sources have reported it between 30 Sep 2026 and 1 Oct 2026.

◆ ◆ The Wire takeaway

Medtronic's new approvals open a clear path to challenge established competitors in pulse field ablation; you should explore partnerships or tech integrations to capture market share fast.

◆ Coverage

2 sources · first reported 30 Sep 2026 · latest 1 Oct 2026

◆ Related on Wire

◆ Topics

Medtechmedtroniccardiac-mappingablation-softwareregulatory-clearancepulse-field-ablation